Prognostic and Risk Stratification Value of Lesion MACC1 Expression in Colorectal Cancer Patients
- PMID: 30805302
- PMCID: PMC6371040
- DOI: 10.3389/fonc.2019.00028
Prognostic and Risk Stratification Value of Lesion MACC1 Expression in Colorectal Cancer Patients
Abstract
The up-regulated metastasis-associated in colon cancer 1 (MACC1) expression and its clinical significance has been explored in a varity of malignancies. In this study, lesion MACC1 expression in 503 CRC patients (N colon = 332, N rectal = 171) were analyzed with immunohistochemistry, and its correlation with clinical parameters, patient survival, and its impact on prognostic stratification were evaluated. Data revealed the survival of patient with MACC1high is markedly worse than that of MACC1low (mean overall survival: 80.1 vs. 90.4 months; p = 0.001) and is an independent prognostic predictor (hazard ratio = 1.533; p = 0.005). More importantly, for the first time, we demonstrated that MACC1 status exhibited a significantly prognostic power for stratified clinical parameters such as patient age and gender, particular TNM status, and distinct AJCC disease stage. In summary, our findings indicated that MACC1 is a valuable prognostic and risk stratification biomarker for colorectal cancer patients.
Keywords: MACC1; colorectal cancer; prognosis; risk stratification; survival.
Figures



Similar articles
-
Prognostic risk stratification value of MACC1 expression in patients with gastric cancer.Clin Transl Oncol. 2025 Jan;27(1):117-125. doi: 10.1007/s12094-024-03550-0. Epub 2024 Jun 13. Clin Transl Oncol. 2025. PMID: 38867026
-
Significance of plasma MACC1 levels on the prognostic stratification in patients with colorectal cancer.J Cell Mol Med. 2019 Feb;23(2):1598-1601. doi: 10.1111/jcmm.13989. Epub 2018 Oct 28. J Cell Mol Med. 2019. PMID: 30370603 Free PMC article.
-
SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.Oncogene. 2016 Nov 17;35(46):5942-5952. doi: 10.1038/onc.2015.451. Epub 2015 Dec 21. Oncogene. 2016. PMID: 26686083
-
MACC1 - a novel target for solid cancers.Expert Opin Ther Targets. 2013 Sep;17(9):1039-52. doi: 10.1517/14728222.2013.815727. Epub 2013 Jul 2. Expert Opin Ther Targets. 2013. PMID: 23815185 Review.
-
The potential therapeutic applications and prognostic significance of metastasis-associated in colon cancer-1 (MACC1) in cancers.Contemp Oncol (Pozn). 2016;20(4):273-80. doi: 10.5114/wo.2016.61846. Epub 2016 Sep 5. Contemp Oncol (Pozn). 2016. PMID: 27688722 Free PMC article. Review.
Cited by
-
Forkhead box D subfamily genes in colorectal cancer: potential biomarkers and therapeutic targets.PeerJ. 2024 Oct 29;12:e18406. doi: 10.7717/peerj.18406. eCollection 2024. PeerJ. 2024. PMID: 39494294 Free PMC article.
-
Elevated MACC1 Expression in Colorectal Cancer Is Driven by Chromosomal Instability and Is Associated with Molecular Subtype and Worse Patient Survival.Cancers (Basel). 2022 Mar 29;14(7):1749. doi: 10.3390/cancers14071749. Cancers (Basel). 2022. PMID: 35406521 Free PMC article.
-
Expression and prognostic significance of Niemann-Pick C1-Like 1 in colorectal cancer: a retrospective cohort study.Lipids Health Dis. 2021 Sep 12;20(1):104. doi: 10.1186/s12944-021-01539-0. Lipids Health Dis. 2021. PMID: 34511128 Free PMC article.
-
Prognostic risk stratification value of MACC1 expression in patients with gastric cancer.Clin Transl Oncol. 2025 Jan;27(1):117-125. doi: 10.1007/s12094-024-03550-0. Epub 2024 Jun 13. Clin Transl Oncol. 2025. PMID: 38867026
-
Important players in carcinogenesis as potential targets in cancer therapy: an update.Oncotarget. 2020 Aug 11;11(32):3078-3101. doi: 10.18632/oncotarget.27689. eCollection 2020 Aug 11. Oncotarget. 2020. PMID: 32850012 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources